COPD is a chronic disease in which effective management requires long-term adherence to pharmacotherapies but the level of adhesion to the prescribed medications is very low and this has a negative influence on outcomes. There are several approaches to detect non-adherence, such as pharmacy refill methods, electronic monitoring, and self-report measures, but they are all burdened with important limitations. Medication adherence in COPD is multifactorial and is affected by patients (health beliefs, cognitive abilities, self-efficacy, comorbidities, psychological profile, conscientiousness), physicians (method of administration, dosing regimen, polypharmacy, side effects), and society (patient-prescriber relationship, social support, access to medication, device training, follow-up). Patient-health care professional communication, especially that between patient and physician or pharmacist, is central to optimizing patient adherence. However, the most realistic approach is to keep in mind that non-adherence is always possible, indeed, probable.
Rogliani, P., Ora, J., Puxeddu, E., Matera, M.g., & Cazzola, M. (2017). Adherence to COPD treatment: Myth and reality. RESPIRATORY MEDICINE, 129, 117-123.
|Tipologia:||Articolo su rivista|
|Citazione:||Rogliani, P., Ora, J., Puxeddu, E., Matera, M.g., & Cazzola, M. (2017). Adherence to COPD treatment: Myth and reality. RESPIRATORY MEDICINE, 129, 117-123.|
|Settore Scientifico Disciplinare:||Settore MED/10 - Malattie dell'Apparato Respiratorio|
|Revisione (peer review):||Esperti anonimi|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1016/j.rmed.2017.06.007|
|Stato di pubblicazione:||Pubblicato|
|Data di pubblicazione:||2017|
|Titolo:||Adherence to COPD treatment: Myth and reality|
|Autori:||Rogliani, P; Ora, J; Puxeddu, E; Matera, Mg; Cazzola, M|
|Appare nelle tipologie:||01 - Articolo su rivista|